Recombinant Human APOBEC4 protein (denatured) (His tag N-Terminus)
Recombinant Human APOBEC4 protein (denatured) (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human APOBEC4 protein (denatured) (His tag N-Terminus) is a Human Full Length protein, in the 1 to 367 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE.
別名を表示する
C1orf169, APOBEC4, Putative C->U-editing enzyme APOBEC-4, Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 4
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human APOBEC4 protein (denatured) (His tag N-Terminus) (AB171472)
15% SDS-PAGE analysis of 3µg ab171472.
Reactivity data
配列情報
出荷温度及び保存条件
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APOBEC4 participates in mutational processes that potentially contribute to genomic diversity. Although detailed functions remain less understood compared to its family members there is evidence to suggest its involvement in germ cell mutation processes. It doesn't expressly form any identified complex like other well-characterized APOBEC members but its potential role might involve interactions that influence genetic sequence variation.
Pathways
APOBEC4's actions can imply a role in pathways involving nucleic acid metabolism. It aligns with pathways linked to RNA modification and potentially impacts the integrity of genetic information during transcription. Other proteins like APOBEC3A and APOBEC3B also participate in similar mutational and editing processes reflecting a possible overlap in pathway involvement that suggests a regulatory network maintaining genetic fidelity.
製品の性状
製品の状態
Liquid
一般的な情報
機能
Putative C to U editing enzyme whose physiological substrate is not yet known.
配列の類似性
Belongs to the cytidine and deoxycytidylate deaminase family.
ターゲットの情報
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com